CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 187 enrolled
Drug / intervention
Verily Sleep Apnea (VSA) Program/Appdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04599803
NCT04599803N/ACompleted
CompareCT.gov

Baseline Sleep Apnea Study #2

Verily Life Sciences LLC·interventional·Posted Oct 23, 2020·Updated Oct 5, 2022

In Brief

A clinical study evaluating Verily Sleep Apnea (VSA) Program/App for Obstructive Sleep Apnea of Adult. Completed, enrolled 187 participants across 1 site.

Detailed Summary

This is a single group, unblinded, prospective clinical study. This study seeks to understand patient diagnostic and treatment journey and positive airway pressure (PAP) therapy compliance for Verily Sleep Apnea (VSA) program/app users. Participants will enroll remotely and may undergo a home sleep test (HST). Upon confirmation of obstructive sleep apnea (OSA) and prescription of PAP therapy, the participant will begin using the VSA app to supplement PAP treatment. After 90 days of active participation, the participant will be given instructions for follow-up care, as indicated.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea of Adult
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedOct 23, 2020
Enrollment StartJul 8, 2020
Primary CompletionMar 30, 2021
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 5.7 years ago

Interventions

Verily Sleep Apnea (VSA) Program/Appdevice

The VSA program/app, is an Obstructive Sleep Apnea (OSA) management platform.